非酒精性脂肪性肝病：疾病负担和疾病认知。
Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness.
机构信息
Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA; Department of Medicine, Center for Liver Disease, Inova Fairfax Medical Campus, 3300 Gallows Road, Falls Church, VA 2202, USA; Inova Medicine, Inova Health System, Falls Church, VA, USA.
Department of Gastroenterology & Hepatology, Federal Research Center for Nutrition and Biotechnology, 21 Kashirskoe Shosse, Moscow 115446, Russia.
出版信息
Clin Liver Dis. 2023 May;27(2):173-186. doi: 10.1016/j.cld.2023.01.001. Epub 2023 Feb 26.
Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide and has been implying an unprecedented burden to health care systems. The prevalence of NAFLD has exceeded 30% in developed countries. Considering the asymptomatic nature of undiagnosed NAFLD, high suspicion and noninvasive diagnosis have utmost importance especially in primary care level. At this point, patient and provider awareness should be optimal for early diagnosis and risk stratification for patients at risk of progression.
非酒精性脂肪性肝病（NAFLD）已成为全球最常见的慢性肝病，给医疗保健系统带来了前所未有的负担。在发达国家，NAFLD 的患病率已超过 30%。鉴于未确诊的 NAFLD 通常没有症状，因此高度怀疑和非侵入性诊断尤为重要，尤其是在初级保健水平。在这一点上，患者和提供者的意识应该是早期诊断和对进展风险患者进行风险分层的最佳选择。
Zotero 插件